연구성과로 돌아가기
JCR 2024 저널 목록 (596 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JOURNAL OF INVESTIGATIVE MEDICINE | SAGE PUBLICATIONS LTD | 1081-5589 | 1708-8267 | SCIE | MEDICINE, GENERAL & INTERNAL | 2,743 | 2.0 | Q2 | 30.3 | 69.7 | 101/332 | 2.1 | Q2 | 1.9 | 0.5 | 0.49 | 118/333 | Q2 | 64.71 | 0.002 | 0.555 | 0.589 | Q2 | 100 | 87.0% | 6.9 | 6.8 | 87 | 3.6% | 2025-08-05 16:04:08 | 바로가기 |
| Journal of Neuroimmune Pharmacology | SPRINGER | 1557-1890 | 1557-1904 | SCIE | PHARMACOLOGY & PHARMACY | 3,337 | 3.5 | Q2 | 30.3 | 69.7 | 107/352 | 5.1 | Q1 | 3.4 | 1.2 | 1.10 | 70/353 | Q1 | 80.31 | 0.003 | 0.572 | 1.306 | Q1 | 56 | 92.9% | 7.9 | 7.0 | 52 | 31.2% | 2025-08-05 16:04:34 | 바로가기 |
| Journal of Transplantation | WILEY | 2090-0007 | 2090-0015 | ESCI | SURGERY | 321 | 2.2 | Q2 | 30.3 | 69.7 | 95/312 | 2.4 | Q2 | 2.2 | 0.3 | 0.58 | 169/312 | Q3 | 45.99 | 0.000 | 0.025 | 0.671 | Q2 | 9 | 88.9% | 11.2 | 8.1 | 8 | 100.0% | 2025-08-05 16:05:23 | 바로가기 |
| MATERIALS AND MANUFACTURING PROCESSES | TAYLOR & FRANCIS INC | 1042-6914 | 1532-2475 | SCIE | ENGINEERING, MANUFACTURING | 9,256 | 4.7 | Q2 | 30.3 | 69.7 | 22/71 | 4.6 | Q2 | 3.6 | 1.1 | 0.81 | 24/71 | Q2 | 66.90 | 0.004 | 0.900 | 0.571 | Q2 | 145 | 94.5% | 6.5 | 4.2 | 137 | 1.1% | 2025-08-05 16:03:09 | 바로가기 |
| Nanotechnology Reviews | DE GRUYTER POLAND SP Z O O | 2191-9089 | 2191-9097 | SCIE | NANOSCIENCE & NANOTECHNOLOGY | 5,702 | 6.1 | Q2 | 30.3 | 69.7 | 45/147 | 6.7 | Q2 | 5.9 | 1.2 | 0.80 | 56/147 | Q2 | 62.24 | 0.005 | 1.088 | 0.970 | Q2 | 170 | 75.3% | 3.7 | 5.2 | 128 | 99.4% | 2025-08-05 16:04:17 | 바로가기 |
| Orthopaedics & Traumatology-Surgery & Research | ELSEVIER MASSON, CORP OFF | 1877-0568 | 1877-0568 | SCIE | SURGERY | 7,797 | 2.2 | Q2 | 30.3 | 69.7 | 95/312 | 2.5 | Q2 | 1.7 | 0.9 | 1.05 | 67/312 | Q1 | 78.69 | 0.007 | 1.519 | 0.667 | Q2 | 187 | 86.1% | 6.6 | 8.5 | 161 | 5.2% | 2025-08-05 16:05:22 | 바로가기 |
| Patient Preference and Adherence | DOVE MEDICAL PRESS LTD | 1177-889X | N/A | SCIE | MEDICINE, GENERAL & INTERNAL | 6,650 | 2.0 | Q2 | 30.3 | 69.7 | 101/332 | 2.5 | Q2 | 1.9 | 0.5 | 0.62 | 91/333 | Q2 | 72.82 | 0.006 | 1.400 | 0.631 | Q2 | 220 | 93.2% | 6.1 | 6.4 | 205 | 99.9% | 2025-08-05 16:04:08 | 바로가기 |
| PHYSICA D-NONLINEAR PHENOMENA | ELSEVIER | 0167-2789 | 1872-8022 | SCIE | PHYSICS, MULTIDISCIPLINARY | 15,072 | 2.9 | Q2 | 30.3 | 69.7 | 35/114 | 3.5 | Q2 | 2.5 | 0.6 | 1.11 | 21/114 | Q1 | 82.02 | 0.009 | 1.962 | 1.034 | Q1 | 352 | 100.0% | 19.9 | 11.8 | 352 | 23.5% | 2025-08-05 16:04:41 | 바로가기 |
| Physical Medicine and Rehabilitation Clinics of North America | W B SAUNDERS CO-ELSEVIER INC | 1047-9651 | 1558-1381 | SCIE | REHABILITATION | 2,564 | 2.0 | Q2 | 30.3 | 69.7 | 53/173 | 2.2 | Q2 | 2.0 | 0.4 | 0.83 | 77/174 | Q2 | 56.03 | 0.001 | 0.299 | 0.590 | Q2 | 56 | 92.9% | 9.6 | 8.6 | 52 | 0.0% | 2025-08-05 16:05:05 | 바로가기 |
| REGULATORY TOXICOLOGY AND PHARMACOLOGY | ACADEMIC PRESS INC ELSEVIER SCIENCE | 0273-2300 | 1096-0295 | SCIE | PHARMACOLOGY & PHARMACY | 10,298 | 3.5 | Q2 | 30.3 | 69.7 | 107/352 | 3.6 | Q2 | 3.1 | 1.4 | 1.22 | 58/353 | Q1 | 83.71 | 0.005 | 1.070 | 0.698 | Q2 | 135 | 97.0% | 8.2 | 8.0 | 131 | 47.6% | 2025-08-05 16:04:33 | 바로가기 |
| Sexual Medicine | OXFORD UNIV PRESS | N/A | 2050-1161 | SCIE | MEDICINE, GENERAL & INTERNAL | 1,606 | 2.0 | Q2 | 30.3 | 69.7 | 101/332 | 2.5 | Q2 | 1.9 | 0.6 | 0.88 | 61/333 | Q1 | 81.83 | 0.003 | 0.579 | 0.701 | Q1 | 74 | 97.3% | 3.9 | 8.4 | 72 | 98.3% | 2025-08-05 16:04:08 | 바로가기 |
| Trauma Surgery & Acute Care Open | BMJ PUBLISHING GROUP | N/A | 2397-5776 | ESCI | SURGERY | 1,512 | 2.2 | Q2 | 30.3 | 69.7 | 95/312 | 2.3 | Q2 | 2.0 | 1.0 | 0.73 | 134/312 | Q2 | 57.21 | 0.003 | 0.654 | 0.804 | Q1 | 143 | 83.2% | 4.0 | 6.7 | 119 | 98.3% | 2025-08-05 16:05:23 | 바로가기 |
| Updates in Surgery | SPRINGER-VERLAG ITALIA SRL | 2038-131X | 2038-3312 | SCIE | SURGERY | 3,063 | 2.2 | Q2 | 30.3 | 69.7 | 95/312 | 2.3 | Q2 | 2.0 | 0.4 | 1.01 | 76/312 | Q1 | 75.80 | 0.005 | 1.026 | 0.594 | Q2 | 303 | 88.4% | 3.7 | 7.0 | 268 | 29.5% | 2025-08-05 16:05:22 | 바로가기 |
| VASCULAR PHARMACOLOGY | ELSEVIER SCIENCE INC | 1537-1891 | 1879-3649 | SCIE | PHARMACOLOGY & PHARMACY | 3,481 | 3.5 | Q2 | 30.3 | 69.7 | 107/352 | 3.6 | Q2 | 3.4 | 0.7 | 1.08 | 72/353 | Q1 | 79.75 | 0.002 | 0.503 | 0.875 | Q2 | 66 | 90.9% | 7.6 | 8.0 | 60 | 26.3% | 2025-08-05 16:04:34 | 바로가기 |
| Administration and Policy in Mental Health and Mental Health Services Research | SPRINGER | 0894-587X | 1573-3289 | SSCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 5,541 | 2.7 | Q2 | 30.4 | 69.6 | 128/419 | 2.9 | Q2 | 2.3 | 1.1 | 0.77 | 160/419 | Q2 | 61.93 | 0.003 | 0.709 | 0.961 | Q2 | 88 | 98.9% | 9.6 | 7.0 | 87 | 39.8% | 2025-08-05 16:04:59 | 바로가기 |
페이지 이동: